S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 41 to 80 of 87

Issue Date	Title / Author(s) / Citation	File
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-07	Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial Baselga, Jose; Im, Seock Ah; Iwata, Hiroji; Cortes, Javier; De laurentiis, Michele; Jiang, Zefei; Arteaga, Carlos L.; Jonat, Walter; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Takahashi, Masato; Vuylsteke, Peter; Hachemi, Soulef; Dharan, Bharani; Di Tomaso, Emmanuelle; Urban, Patrick; Massacesi, Cristian; Campone, Mario The Lancet Oncology, Vol.18 No.7, pp.904-916	DOI
2017-09	Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang; Dowsett, Mitchell Oncologist, Vol.22 No.9, pp.1028-1038	DOI
2017-09	Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial Cortes, Javier; Rugo, Hope S.; Awada, Ahmad; Twelves, Chris; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; O'Shaughnessy, Joyce Breast Cancer Research and Treatment, Vol.165 No.2, pp.329-341	DOI
2017-10	Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Kim, Sung-Bae; Dent, Rebecca; Im, Seock-Ah; Espie, Marc; Blau, Sibel; Tan, Antoinette R.; Isakoff, Steven J.; Oliveira, Mafalda; Saura, Cristina; Wongchenko, Matthew J.; Kapp, Amy V.; Chan, Wai Y.; Singel, Stina M.; Maslyar, Daniel J.; Baselga, Jose The Lancet Oncology, Vol.18 No.10, pp.1360-1372	DOI
2017-10	Efficacy of sequential ipilimumab monotherapy versus best supportive care for unresectable locally advanced/metastatic gastric or gastroesophageal junction cancer Bang, Yung-Jue; Cho, Jae Yong; Kim, Yeul Hong; Kim, Jin Won; Di Bartolomeo, Maria; Ajani, Jaffer A.; Yamaguchi, Kensei; Balogh, Agnes; Sanchez, Teresa; Moehler, Markus Clinical Cancer Research, Vol.23 No.19, pp.5671-5678	DOI
2018-03	Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases Turner, N. C.; Finn, R. S.; Martin, M.; Im, S. -A; DeMichele, A.; Ettl, J.; Dieras, V.; Moulder, S.; Lipatov, O.; Colleoni, M.; Cristofanilli, M.; Lu, D. R.; Mori, A.; Giorgetti, C.; Iyer, S.; Bartlett, C. Huang; Gelmon, K. A. Annals of Oncology, Vol.29 No.3, pp.669-680	DOI
2018-09	Integrated multi-omic analyses support distinguishing secretory carcinoma of the breast from basal-like triple-negative breast cancer Jin, Min-Sun; Lee, Hyebin; Woo, Jongmin; Choi, Seongmin; Do, Mi Sol; Kim, Kwangsoo; Song, Min Ji; Kim, Youngsoo; Park, In Ae; Han, Dohyun; Ryu, Han Suk Proteomics - Clinical Applications, Vol.12 No.5, p. 1700125	view file DOI
2018-11	Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3 Cristofanilli, Massimo; DeMichele, Angela; Giorgetti, Carla; Turner, Nicholas C.; Slamon, Dennis J.; Im, Seock-Ah; Masuda, Norikazu; Verma, Shailendra; Loi, Sherene; Colleoni, Marco; Theall, Kathy Puyana; Huang, Xin; Liu, Yuan; Bartlett, Cynthia Huang European Journal of Cancer, Vol.104, pp.21-31	DOI
2018-11	Overall survival with palbociclib and fulvestrant in advanced breast cancer Turner, Nicholas C.; Slamon, Dennis J.; Ro, Jungsil; Bondarenko, Igor; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Andre, Fabrice; Theall, K. Puyana; Huang, Xin; Giorgetti, Carla; Bartlett, C. Huang; Cristofanilli, Massimo New England Journal of Medicine, Vol.379 No.20, pp.1926-1936	DOI
2018-11	Phase Ib/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factor-dysregulated non-small-cell lung cancer Wu, Yi-Long; Zhang, Li; Kim, Dong-Wan; Liu, Xiaoqing; Lee, Dae Ho; Yang, James Chih-Hsin; Ahn, Myung-Ju; Vansteenkiste, Johan F.; Su, Wu-Chou; Felip, Enriqueta; Chia, Vincent; Glaser, Sabine; Pultar, Philippe; Zhao, Sylvia; Peng, Bin; Akimov, Mikhail; Tan, Daniel S. W. Journal of Clinical Oncology, Vol.36 No.31, pp.3101-3109	DOI
2018-12	Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy Jeon, Seung Hyuck; Shin, Kyung Hwan; Kim, Jin Ho; Kim, Kyubo; Kim, In Ah; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.172 No.3, pp.619-626	DOI
2019-01	MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer Johnston, Stephen; Martin, Miguel; Di Leo, Angelo; Im, Seock-Ah; Awada, Ahmad; Forrester, Tammy; Frenzel, Martin; Hardebeck, Molly C.; Cox, Joanne; Barriga, Susana; Toi, Masakazu; Iwata, Hiroji; Goetz, Matthew P. npj Breast Cancer, Vol.5 No.1, p. 5	DOI
2019-02	The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines Choi, Hyeong Sim; Kim, Young Kyun; Yun, Pil Young Molecular Biology Reports, Vol.46 No.1, pp.617-625	DOI
2019-04	Development of a patient-derived xenograft model of glioblastoma via intravitreal injection in mice Lee, Jooyoung; Jo, Dong Hyun; Kim, Jin Hyoung; Cho, Chang Sik; Han, Jiwon Esther; Kim, Yona; Park, Hyoungwoo; Yoo, Seung Ho; Yu, Young Suk; Moon, Hyo Eun; Park, Hye Ran; Kim, Dong Gyu; Kim, Jeong Hun; Paek, Sun Ha Experimental and Molecular Medicine, Vol.51 No.4, pp.1-9	DOI
2019-05	Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: Results from the phase III, randomized PALOMA-2 study Im, Seock-Ah; Mukai, Hirofumi; Park, In Hae; Masuda, Norikazu; Shimizu, Chikako; Kim, Sung-Bae; Im, Young-Hyuck; Ohtani, Shoichiro; Bartlett, Cynthia Huang; Lu, Dongrui R.; Iyer, Shrividya; Mori, Yuko; Mori, Ave; Gauthier, Eric; Finn, Richard S.; Toi, Masakazu Journal of Global Oncology, Vol.2019 No.5, pp.1-19	DOI
2019-07	Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors Hellmann, M. D.; Kim, T. -W.; Lee, C. B.; Goh, B-C; Miller, W. H., Jr.; Oh, D. -Y.; Jamal, R.; Chee, C. -E.; Chow, L. Q. M.; Gainor, J. F.; Desai, J.; Solomon, B. J.; Das Thakur, M.; Pitcher, B.; Foster, P.; Hernandez, G.; Wongchenko, M. J.; Cha, E.; Bang, Y. -J.; Siu, L. L.; Bendell, J. Annals of Oncology, Vol.30 No.7, pp.1134-1142	DOI
2019-07	Overall survival with ribociclib plus endocrine therapy in breast cancer Im, Seock-Ah; Lu, Yen-Shen; Bardia, Aditya; Harbeck, Nadia; Colleoni, Marco; Franke, Fabio; Chow, Louis; Sohn, Joohyuk; Lee, Keun-Seok; Campos-Gomez, Saul; Villanueva-Vazquez, Rafael; Jung, Kyung-Hae; Chakravartty, Arunava; Hughes, Gareth; Gounaris, Ioannis; Rodriguez-Lorenc, Karen; Taran, Tetiana; Hurvitz, Sara; Tripathy, Debu New England Journal of Medicine, Vol.381 No.4, pp.307-316	DOI
2019-10	Treating HR+/HER2-breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression Yeo, Winnie; Ueno, Takayuki; Lin, Ching-Hung; Liu, Qiang; Lee, Kyung-Hun; Leung, Roland; Naito, Yoichi; Park, Yeon Hee; Im, Seock-Ah; Li, Huiping; Yap, Yoon Sim; Lu, Yen-Shen Breast Cancer Research and Treatment, Vol.177 No.3, pp.549-559	DOI
2020-01	Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naive Metastatic Breast Cancer Finn, Richard S.; Liu, Yuan; Zhu, Zhou; Martin, Miguel; Rugo, Hope S.; Dieras, Veronique; Im, Seock-Ah; Gelmon, Karen A.; Harbeck, Nadia; Lu, Dongrui R.; Gauthier, Eric; Bartlett, Cynthia Huang; Slamon, Dennis J. Clinical Cancer Research, Vol.26 No.1, pp.110-121	DOI
2020-03	Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies Ettl, Johannes; Im, Seock-Ah; Ro, Jungsil; Masuda, Norikazu; Colleoni, Marco; Schnell, Patrick; Bananis, Eustratios; Lu, Dongrui R.; Cristofanilli, Massimo; Rugo, Hope S.; Finn, Richard S. Breast Cancer Research, Vol.22 No.1, p. 27	DOI
2020-03	Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer Paik, E. Sun; Kim, Tae-Hyun; Cho, Young Jae; Ryu, Jiyoon; Choi, Jung-Joo; Lee, Yoo-Young; Kim, Tae-Joong; Choi, Chel-Hun; Kim, Woo Young; Sa, Jason K.; Lee, Jin-Ku; Kim, Byoung-Gie; Bae, Duk-Soo; Han, Hee Dong; Ahn, Hyung Jun; Lee, Jeong-Won Scientific Reports, Vol.10 No.1, p. 4904	DOI
2020-04	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Swain, Sandra M.; Miles, David; Kim, Sung-Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefania; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C.; Cortes, Javier The Lancet Oncology, Vol.21 No.4, pp.519-530	DOI
2020-04	Facilitated Transdermal Drug Delivery Using Nanocarriers-Embedded Electroconductive Hydrogel Coupled with Reverse Electrodialysis-Driven Iontophoresis An, Young-Hyeon; Lee, Joon; Son, Dong Uk; Kang, Dong Hyeon; Park, Mihn Jeong; Cho, Kyoung Won; Kim, Semin; Kim, Su-Hwan; Ko, Junghyeon; Jang, Myoung-Hoon; Lee, Jae Young; Kim, Dae-Hyeong; Hwang, Nathaniel S. ACS Nano, Vol.14 No.4, pp.4523-4535	DOI
2020-06	NMR-based metabolic profiling discriminates the geographical origin of raw sesame seeds Kim, Seok-Young; Kim, EunBi; Shin, Byeung Kon; Seo, Jeong-Ah; Kim, Young-Suk; Lee, Do Yup; Choi, Hyung-Kyoon Food Control, Vol.112, p. 107113	DOI
2020-08	Preparation and evaluation of Eudragit L100-PEG proliponiosomes for enhanced oral delivery of celecoxib Kim, Min-Hwan; Kim, Dong Hyun; Nguyen, Duy-Thuc; Lee, Han Sol; Kang, Nae-Won; Baek, Min-Jun; An, Jiseon; Yoo, So-Yeol; Mun, Yong-Hyeon; Lee, Wonhwa; Kim, Ki-Taek; Cho, Cheong-Weon; Lee, Jae-Young; Kim, Dae-Duk Pharmaceutics, Vol.12 No.8, pp.1-14	DOI
2020-08	Model discrepancy of Earth polar motion using topological data analysis and convolutional neural network analysis Lee, Dongjin; Bresten, Christopher; Youm, Kookhyoun; Seo, Ki-Weon; Jung, Jae-Hun International Journal of Modern Physics C, Vol.31 No.8, p. 2050117	DOI
2020-08	S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial Kang, Yoon-Koo; Chin, Keisho; Chung, Hyun Cheol; Kadowaki, Shigenori; Oh, Sang Cheul; Nakayama, Norisuke; Lee, Keun-Wook; Hara, Hiroki; Chung, Ik-Joo; Tsuda, Masahiro; Park, Se Hoon; Hosaka, Hisashi; Hironaka, Shuichi; Miyata, Yoshinori; Ryu, Min-Hee; Baba, Hideo; Hyodo, Ichinosuke; Bang, Yung-Jue; Boku, Narikazu The Lancet Oncology, Vol.21 No.8, pp.1045-1056	DOI
2020-09	Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ) Bang, Yung-Jue; Golan, Talia; Dahan, Laetitia; Fu, Siqing; Moreno, Victor; Park, Keunchil; Geva, Ravit; De Braud, Filippo; Wainberg, Zev A.; Reck, Martin; Goff, Laura; Laing, Naomi; Mi, Gu; Oliveira, Joana M.; Wasserstrom, Heather; Lin, Chia-Chi European Journal of Cancer, Vol.137, pp.272-284	DOI
2020-12	Increased FOXM1 expression by cisplatin inhibits paclitaxel-related apoptosis in cisplatin-resistant human oral squamous cell carcinoma (OSCC) cell lines Choi, Hyeong Sim; Kim, Young Kyun; Hwang, Kyung Gyun; Yun, Pil Young International Journal of Molecular Sciences, Vol.21 No.23, pp.8897-12	DOI
2021-01	Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-X-L inhibitor ABT-263 in KRAS-mutant colorectal cancers Oh, Yumi; Jung, Hae Rim; Min, Seoyeon; Kang, Jinjoo; Jang, Dongjun; Shin, Seungjae; Kim, Jiwon; Lee, Sang Eun; Sung, Chang Ohk; Lee, Won-Suk; Lee, Charles; Jeong, Eui Man; Cho, Sung Yup Cancer Letters, Vol.497, pp.123-136	DOI
2021-03	Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial Patnaik, Amita; Yap, Timothy A.; Chung, Hyun Cheol; de Miguel, Maria J.; Bang, Yung-Jue; Lin, Chia-Chi; Su, Wu-Chou; Italiano, Antoine; Chow, Kay Hoong; Szpurka, Anna M.; Yu, Danni; Zhao, Yumin; Carlsen, Michelle; Schmidt, Shelly; Vangerow, Burkhard; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna Clinical Cancer Research, Vol.27 No.5, pp.1267-1277	DOI
2021-04	Prognosis of single tooth implants following alveolar ridge preservation with two recombinant human bone morphogenetic protein-2 delivery systems Baek, Hyeong Jin; Kim, Il hyung; Yun, Pil Young; Kim, Young Kyun BMC Oral Health, Vol.21 No.1, p. 201	DOI
2021-04	Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial Winer, Eric P.; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Munoz-Couselo, Eva; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Zhou, Xuan; Karantza, Vassiliki; Mejia, Jaime; Cortes, Javier The Lancet Oncology, Vol.22 No.4, pp.499-511	DOI
2021-05	Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1(+) Activated T Cells Dovedi, Simon J.; Elder, Matthew J.; Yang, Chunning; Sitnikova, Suzanne, I; Irving, Lorraine; Hansen, Anna; Hair, James; Jones, Des C.; Hasani, Sumati; Wang, Bo; Im, Seock-Ah; Ben Tran; Subramaniam, Deepa S.; Gainer, Shelby D.; Vashisht, Kapil; Lewis, Arthur; Jin, Xiaofang; Kentner, Stacy; Mulgrew, Kathy; Wang, Yaya; Overstreet, Michael G.; Dodgson, James; Wu, Yanli; Palazon, Asis; Morrow, Michelle; Rainey, Godfrey J.; Browne, Gareth J.; Neal, Frances; Murray, Thomas, V; Toloczko, Aleksandra D.; Dall'Acqua, William; Achour, Ikbel; Freeman, Daniel J.; Wilkinson, Robert W.; Mazor, Yariv Cancer Discovery, Vol.11 No.5, pp.1100-1117	DOI
2021-12	Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors Italiano, Antoine; Miller, Wilson H., Jr.; Blay, Jean-Yves; Gietema, Jourik A.; Bang, Yung-Jue; Mileshkin, Linda R.; Hirte, Hal W.; Higgins, Brian; Blotner, Steven; Nichols, Gwen L.; Chen, Lin Chi; Petry, Claire; Yang, Qi Joy; Schmitt, Christophe; Jamois, Candice; Siu, Lillian L. Investigational New Drugs, Vol.39 No.6, pp.1587-1597	DOI
2022-02	Trastuzumab Emtansine plus Pertuzumab Versus Taxane plus Trastuzumab plus Pertuzumab after Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study Krop, Ian E.; Im, Seock-Ah; Barrios, Carlos; Bonnefoi, Hervé; Gralow, Julie; Toi, Masakazu; Ellis, Paul A.; Gianni, Luca; Swain, Sandra M.; Im, Young-Hyuck; De Laurentiis, Michelino; Nowecki, Zbigniew; Huang, Chiun-Sheng; Fehrenbacher, Louis; Ito, Yoshinori; Shah, Jigna; Boulet, Thomas; Liu, Haiying; Macharia, Harrison; Trask, Peter; Song, Chunyan; Winer, Eric P.; Harbeck, Nadia Journal of Clinical Oncology, Vol.40 No.5, pp.438-448	DOI
2022-08	First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors Kim, Tae Won; Burris, Howard A.; Luken, Maria J. de Miguel; Pishvaian, Michael J.; Bang, Yung-Jue; Gordon, Michael; Awada, Ahmad; Camidge, D. Ross; Hodi, F. Stephen; McArthur, Grant A.; Miller, Wilson H., Jr.; Cervantes, Andres; Chow, Laura Q.; Lesokhin, Alexander M.; Rutten, Annemie; Sznol, Mario; Rishipathak, Deepali; Chen, Shang-Chiung; Stefanich, Eric; Pourmohamad, Tony; Anderson, Maria; Kim, Jeong; Huseni, Mahrukh; Rhee, Ina; Siu, Lillian L. Clinical Cancer Research, Vol.28 No.16, pp.3452-3463	DOI
2022-09	Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel +/- Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Shah, Manish A.; Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Tebbutt, Niall C.; Metges, Jean-Phillippe; Muro, Kei; Lee, Keun-Wook; Shen, Lin; Tjulandin, Sergei; Hays, John L.; Starling, Naureen; Xu, Rui-Hua; Sturtz, Keren; Fontaine, Marilyn; Oh, Cindy; Brooks, Emily M.; Xu, Bo; Li, Wei; Li, Chiang J.; Borodyansky, Laura; Van Cutsem, Eric Clinical Cancer Research, Vol.28 No.17, pp.3686-3694	DOI

1 2 3